BioNJ, President and CEO
Debbie Hart, President and CEO of BioNJ, worked alongside New Jersey’s biotechnology industry leaders to establish BioNJ in 1994. BioNJ seeks to promote a business and public policy environment in New Jersey, Washington,D.C. and beyond that advances the growth and prosperity of New Jersey’s biotechnology companies.
Debbie has been active with the boards and committees of numerous government and academic institutions.
She served on the transition teams of two former New Jersey governors and was recently appointed by Gov. Chris Christie and Lt. Governor Kim Guadagno to the Council on Innovation. She is a member of the New Jersey Economic Development Authority’s (EDA) Technology Advisory Board and is a member and former Chair of EDA’s Commercialization Center for Innovative Technology of New Jersey (CCIT) and was appointed by two Governors to the New Jersey Israel Commission for her work in economic development.
Past government support activities include the Prosperity New Jersey Pharmaceutical and Biotechnology Cluster Study commissioned by a former Governor and conducted by Professor Michael Porter of the Harvard Business School, the Jobs Growth and Economic Development Commission and the Task Force on Higher Education Quality and Competitiveness of the State. Hart also served on the Business Task Force established in 2011 by the New Jersey State Legislature.
A strong advocate for advancing education, she is a board member of the Rutgers University Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management at Rutgers University Business School, the Science Advisory Board at Rider University and the Advisory Board of the College of Science and Mathematics at Montclair University and a former board member of the Rothman Institute of Entrepreneurship at Fairleigh Dickinson University’s Silberman College of Business.
Debbie has served on advisory boards for the New Jersey Institute of Technology’s (NJIT) Biomedical Engineering Program, Monmouth University’s School of Science, Technology and Engineering and the New Jersey Healthcare Businesswomen’s Association (HBA) Advisory Board. She served on the advisory board that guided and supported the establishment of the nationally recognized Monmouth County Biotechnology High School. In 2005, Debbie delivered the Commencement Address at Raritan Valley Community College’s graduation ceremonies.
As an advocate for the industry, Debbie has spoken before State and federal legislative committees. She is also a frequent speaker at industry events, including serving as the Keynote speaker at the 2011 Russian Pharmaceutical Forum in St. Petersburg and the 2011 Knowledge for Growth Conference in Ghent, Belgium as well as the Women’s Clinical Leadership Forum at the Partnerships in Clinical Trials conference in Orlando, Florida in 2012.
Hart has been honored by the Women’s Fund of New Jersey as a Woman Advancing Science, and she and BioNJ have been recognized by NJIT with a New Jersey Inventors Hall of Fame Award. She was named in 2011 and 2012 to the NJBIZ Power 100, a listing of the 100 most influential people in New Jersey business and is a NJBIZ New Jersey’s Best 50 Women in Business honoree. In March 2014 in commemoration of Women’s History Month, she was honored by the New Jersey General Assembly. In May, Debbie was named as one of 50 people to PolitickerNJ’s Health Care Power List of 2014.
Debbie holds an M.S. from the S.I. Newhouse School at Syracuse University where she graduated cum laude and a B.A. from Trenton State College, now The College of New Jersey, where she graduated magna cum laude.